1. Home
  2. GNFT vs ELLO Comparison

GNFT vs ELLO Comparison

Compare GNFT & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • ELLO
  • Stock Information
  • Founded
  • GNFT 1999
  • ELLO 1987
  • Country
  • GNFT France
  • ELLO Israel
  • Employees
  • GNFT N/A
  • ELLO N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • ELLO Electric Utilities: Central
  • Sector
  • GNFT Health Care
  • ELLO Utilities
  • Exchange
  • GNFT Nasdaq
  • ELLO Nasdaq
  • Market Cap
  • GNFT 186.3M
  • ELLO 208.2M
  • IPO Year
  • GNFT 2019
  • ELLO 1995
  • Fundamental
  • Price
  • GNFT $4.14
  • ELLO $17.60
  • Analyst Decision
  • GNFT Strong Buy
  • ELLO
  • Analyst Count
  • GNFT 1
  • ELLO 0
  • Target Price
  • GNFT $13.00
  • ELLO N/A
  • AVG Volume (30 Days)
  • GNFT 4.0K
  • ELLO 10.3K
  • Earning Date
  • GNFT 09-18-2025
  • ELLO 06-30-2025
  • Dividend Yield
  • GNFT N/A
  • ELLO N/A
  • EPS Growth
  • GNFT N/A
  • ELLO N/A
  • EPS
  • GNFT 0.03
  • ELLO 0.43
  • Revenue
  • GNFT $73,187,701.00
  • ELLO $44,405,534.00
  • Revenue This Year
  • GNFT $15.98
  • ELLO N/A
  • Revenue Next Year
  • GNFT N/A
  • ELLO N/A
  • P/E Ratio
  • GNFT $132.83
  • ELLO $45.49
  • Revenue Growth
  • GNFT 105.01
  • ELLO N/A
  • 52 Week Low
  • GNFT $2.55
  • ELLO $11.30
  • 52 Week High
  • GNFT $6.42
  • ELLO $20.81
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 58.36
  • ELLO 59.29
  • Support Level
  • GNFT $3.94
  • ELLO $17.00
  • Resistance Level
  • GNFT $4.20
  • ELLO $17.84
  • Average True Range (ATR)
  • GNFT 0.13
  • ELLO 0.55
  • MACD
  • GNFT 0.05
  • ELLO -0.02
  • Stochastic Oscillator
  • GNFT 91.62
  • ELLO 75.86

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About ELLO Ellomay Capital Ltd (Israel)

Ellomay Capital Ltd is focused on the utility sector. It is an Israeli public company, which focuses its business in the energy and infrastructure sectors. The company's operating segment includes Photovoltaic power plants (PV Plants); Dorad Energy Ltd. (Dorad); Groen Gas Goor B.V. and a Pumped storage hydro power plant (Manara). It generates maximum revenue from the Dorad segment. Geographically, it derives a majority of its revenue from Spain.

Share on Social Networks: